Targeting Nuclear Hormone Receptors in Castration-Resistant Prostate Cancer Trials Within the PCCC


Dr. Russell Szmulewitz, assistant professor of medicine, discusses whether or not standard drugs are being used appropriately/efficiently and should physicians continue these medicines past progression as done for castration.  Dr. Szmulewitz also examines how to target/treat resistant disease.



Russell Szmulewitz

Russell Szmulewitz, MD

Assistant Professor of Medicine

Admissions, Referrals and Consultations:

Call UCM Physician Connect at
Contact Us

Sign Up for Email Newsletters

Learn more >